N-(6-fluoro-2-methyl-3-(5-(5-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-ylamino)-6-oxo-1,6-dihydropyridazin-3-yl)phenyl)thieno[2,3-b]pyridine-2-carboxamide

ID: ALA3747130

Chembl Id: CHEMBL3747130

PubChem CID: 46223487

Max Phase: Preclinical

Molecular Formula: C26H23FN8O2S

Molecular Weight: 530.59

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2cccnc2s1

Standard InChI:  InChI=1S/C26H23FN8O2S/c1-14-17(5-6-18(27)23(14)30-25(37)21-10-15-4-3-7-28-26(15)38-21)19-12-20(24(36)32-31-19)29-22-11-16-13-34(2)8-9-35(16)33-22/h3-7,10-12H,8-9,13H2,1-2H3,(H,30,37)(H,32,36)(H,29,31,33)

Standard InChI Key:  VAGVVMNSGHHXHT-UHFFFAOYSA-N

Associated Targets(Human)

Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BTK Tclin Tyrosine-protein kinase BTK (8973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Btk Tyrosine-protein kinase BTK (130 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 530.59Molecular Weight (Monoisotopic): 530.1649AlogP: 4.13#Rotatable Bonds: 5
Polar Surface Area: 120.83Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.02CX Basic pKa: 8.29CX LogP: 3.05CX LogD: 2.22
Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.31Np Likeness Score: -1.71

References

1. Young WB, Barbosa J, Blomgren P, Bremer MC, Crawford JJ, Dambach D, Eigenbrot C, Gallion S, Johnson AR, Kropf JE, Lee SH, Liu L, Lubach JW, Macaluso J, Maciejewski P, Mitchell SA, Ortwine DF, Di Paolo J, Reif K, Scheerens H, Schmitt A, Wang X, Wong H, Xiong JM, Xu J, Yu C, Zhao Z, Currie KS..  (2016)  Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability.,  26  (2): [PMID:26675441] [10.1016/j.bmcl.2015.11.076]

Source